4.7 Article

Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors

Related references

Note: Only part of the references are listed.
Article Oncology

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

Jason Fangusaro et al.

Summary: This study presented the results of treating children with recurrent/progressive OPHGs using selumetinib in a PBTC phase II trial. The treatment resulted in partial responses in 24% of patients, stable disease in 56%, and disease progression in 20%, with a median number of 26 treatment courses. The two-year PFS was 78%, and evaluation of visual acuity showed improvement and stability in a portion of patients.

NEURO-ONCOLOGY (2021)

Article Neurosciences

Decoding neuronal composition and ontogeny of individual hypothalamic nuclei

Tong Ma et al.

Summary: The hypothalamus plays important roles in regulating various functions. This study reveals the cellular mechanisms underlying the generation and organization of diverse neuronal subtypes in the mammalian hypothalamus.

NEURON (2021)

Article Genetics & Heredity

Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies

Andrea M. Gross et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2020)

Article Multidisciplinary Sciences

Cellular and molecular properties of neural progenitors in the developing mammalian hypothalamus

Xin Zhou et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

The duality of human oncoproteins: drivers of cancer and congenital disorders

Pau Castel et al.

NATURE REVIEWS CANCER (2020)

Article Genetics & Heredity

Costello syndrome: Clinical phenotype, genotype, and management guidelines

Karen W. Gripp et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Article Multidisciplinary Sciences

Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells

Zachary J. Reitman et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

The molecular landscape of glioma in patients with Neurofibromatosis 1

Fulvio D'Angelo et al.

NATURE MEDICINE (2019)

Review Oncology

Pediatric low-grade gliomas: next biologically driven steps

David T. W. Jones et al.

NEURO-ONCOLOGY (2018)

Review Biochemistry & Molecular Biology

Origin of Oligodendrocytes in the Vertebrate Optic Nerve: A Review

Katsuhiko Ono et al.

NEUROCHEMICAL RESEARCH (2018)

Article Genetics & Heredity

Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1

Laura Sellmer et al.

ORPHANET JOURNAL OF RARE DISEASES (2018)

Article Multidisciplinary Sciences

CANCER ETIOLOGY Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention

Cristian Tomasetti et al.

SCIENCE (2017)

Article Medicine, General & Internal

Neurofibromatosis type 1

David H. Gutmann et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Developmental Biology

Oligodendrocyte development in the embryonic tuberal hypothalamus and the influence of Ascl1

Candace M. Marsters et al.

NEURAL DEVELOPMENT (2016)

Review Anatomy & Morphology

Development of Astrocytes in the Vertebrate Eye

Chenqi Tao et al.

DEVELOPMENTAL DYNAMICS (2014)

Article Multidisciplinary Sciences

eulerAPE: Drawing Area-Proportional 3-Venn Diagrams Using Ellipses

Luana Micallef et al.

PLOS ONE (2014)

Article Neurosciences

MEK Is a Key Regulator of Gliogenesis in the Developing Brain

Xiaoyan Li et al.

NEURON (2012)

Article Biochemistry & Molecular Biology

Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma

Chong Liu et al.

Article Clinical Neurology

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

KL Ligon et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)